Receptor Specific Peptides for Bcl-2 Family Anti-apoptotic Proteins
Invention type: Technology
/
Case number: #20337J
Provided herein are peptides selective for combinations of Mcl-1/Bfl-1/Bcl-xL. Also provided are compositions containing these polypeptides and methods of using such peptides in the treatment of cancer that include administering to a subject one of the polypeptides.
Researchers
Amy Keating
/ Gevorg Grigoryan
/ Justin Jenson
/ Vincent Xue
/ Jianfu Zhou
Departments: DLC Heads Science
Technology Areas: Chemicals & Materials: Polymers / Therapeutics: Proteins & Antibodies
Impact Areas: Healthy Living
-
peptides selective for bcl-2 family proteins
United States of America | Granted | 11,286,299
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.